JPMORGAN CHASE & CO - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 46 filers reported holding LARIMAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$109,451
-43.6%
27,709
-55.3%
0.00%
Q2 2023$194,076
-93.6%
62,005
-90.8%
0.00%
Q1 2023$3,044,000
+1645305.4%
671,857
+1400.0%
0.00%
Q4 2022$185
-95.4%
44,790
+3877.8%
0.00%
Q3 2022$4,0000.0%1,126
-43.8%
0.00%
Q2 2022$4,000
-55.6%
2,004
-4.6%
0.00%
Q1 2022$9,000
-47.1%
2,101
+33.1%
0.00%
Q4 2021$17,000
+30.8%
1,578
+41.9%
0.00%
Q3 2021$13,000
+85.7%
1,112
+48.1%
0.00%
Q2 2021$7,000751
+6158.3%
0.00%
Q1 2021$0120.0%0.00%
Q4 2020$0120.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 2,746,265$12,440,5803.30%
Opaleye Management Inc. 1,401,000$6,346,5301.90%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,941,357$76,744,3471.71%
GREAT POINT PARTNERS LLC 900,000$4,077,0000.80%
DAFNA Capital Management LLC 236,873$1,073,0350.32%
Perceptive Advisors 2,280,709$10,331,6120.30%
Atlas Venture Advisors, Inc. 292,184$1,323,5940.28%
MANGROVE PARTNERS IM, LLC 805,815$3,650,3420.24%
Verition Fund Management LLC 1,938,822$8,782,8640.12%
Woodline Partners LP 1,681,913$7,619,0660.10%
View complete list of LARIMAR THERAPEUTICS INC shareholders